Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Systematic review and meta-analysis on targeted therapy in advanced pancreatic cancer.

Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.] - 1 Jan 2000

Ciliberto Domenico, Staropoli Nicoletta, Chiellino Silvia, Botta Cirino, Tassone Pierfrancesco, Tagliaferri Pierosandro

Abstract excerpt

AIM: A systematic review and meta-analysis from literature has been performed to assess the impact of targeted therapy in advanced pancreatic cancer. METHODS: By searching different literature databases and major cancer meetings proceedings, data from all randomized clinical trials designed to investigate molecular targeted agents in the treatment of advanced pancreatic cancer were collected. The time-frame...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antineoplastic Agents
Share to Antineoplastic Combined Chemotherapy Protocols

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to EGFR gene

Share to Genetic Predisposition to Disease

Share to Pancreatic Neoplasms

Share to Signal Transduction

Source

Identifiers

PMID: 26852170
DOI: 10.1016/j.pan.2016.01.003

Genes

EGFR

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Systematic review and meta-analysis on targeted therapy in advanced pancreatic cancer.PMID 26852170Read ↗

Systemic therapy for advanced pancreatic cancer: individualising cytotoxic therapy.Semantic proximity Read ↗

Immunotherapy Combined with Chemotherapy versus Chemotherapy Alone in Advanced Pancreatic Ductal Adenocarcinoma: a Real-world Retrospective Cohort StudySemantic proximity Read ↗

Recent advances in the treatment of pancreatic cancerSemantic proximity Read ↗

Emerging drugs in the treatment of pancreatic cancer.Semantic proximity Read ↗

Advances in the Treatment of Pancreatic CancerSemantic proximity Read ↗

Identification of novel candidate biomarkers and efficacious small molecule drugs for pancreatic adenocarcinoma based on comprehensive bioinformatics technologySemantic proximity Read ↗

Molecular targeted therapies for pancreatic cancer.Semantic proximity Read ↗

Erlotinib is effective in pancreatic cancer with epidermal growth factor receptor mutations: a randomized, open-label, prospective trial.Semantic proximity Read ↗

Current and future therapies for advanced pancreatic cancer.Semantic proximity Read ↗

Available technologies and clinical applications of targeted chemotherapy in pancreatic cancer.Semantic proximity Read ↗

Prognostic value of KRAS gene mutations in pancreatic ductal adenocarcinoma: a systematic review and meta-analysis.Semantic proximity Read ↗

KRAS Inhibition in Pancreatic Cancer: Pooled Efficacy and Safety Signals from Early-Phase StudiesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.